
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)
Keywords: Adult T-cell leukaemia lymphoma; HTLV-1; Anti-CD25 antibodies;